Home > Animal Health & Nutrition > Veterinary Services > Animal Healthcare Market
Based on product, the animal healthcare market is segmented as pharmaceuticals, medical devices, and veterinary services. The veterinary services segment is expected to reach around USD 76 billion by 2032. This high market revenue is owing to several advantages offered by veterinary services in animal healthcare. In addition, as the risk of zoonotic diseases grows, veterinary clinics provide a variety of services to prevent and manage veterinary infectious diseases.
Based on animal type, animal healthcare market is segmented as livestock animals, and companion animals. The companion animals segment accounted for around USD 93.4 billion in 2022 and is set to witness a CAGR of over 4.4% through 2032. This is due to the fact that companion animals are proven to reduce blood pressure, provide psychological stability, and reduce the incidence of cardiac arrhythmias and anxiety symptoms, all of which improve human well-being.
Based on distribution channel, The industry is divided into three segmented as pharmacies, online, and distributors. The distributors category is expected to expand at a lucrative 3.8% CAGR from 2023 to 2032. This increased segmental share is due to veterinary distributors sell veterinary goods made by animal health companies. They frequently use their own distributor representative sales team to help veterinary clinics and hospitals detail animal care products/services. The method of distribution is sometimes determined by the product's approval pathway and prescription regulations, such as whether the product must be dispensed by or on the order of a certified veterinarian. Some products can be disseminated to pet owners immediately through retail outlets.
North America animal healthcare market accounted for 39.4% revenue share in 2022, due to a variety of definitive measures implemented by government animal welfare organizations that are constantly working to better overall animal health. Furthermore, technological advancements, rising zoonotic disease incidence, and an increasing number of pet owners are expected to drive market expansion in the region. Several collaborative efforts by major businesses to improve their R&D capabilities and ensure high-quality standards are anticipated to drive demand in this region even higher. Furthermore, the bulk of the share can be attributed to the high disease burden in this region.